Navigation Links
UC Davis bench-to-bedside research: Promising treatment in clinical trials
Date:3/26/2009

DAVIS, CALIF.A new drug developed at the University of California, Davis to treat diabetes, hypertension and inflammatory has entered Phase II of human clinical trials to evaluate its efficacy.

The compound, a soluble epoxide hydrolase enzyme (s-EH) inhibitor, is "a first-in-class drug which may treat a suite of major cardiovascular and metabolic diseases," said entomologist Bruce Hammock, who with UC Berkeley cell biologist Sarjeet Gill discovered the enzyme in 1969 while researching fundamental insect biology.

"This is one of the few examples of basic research in an academic laboratory moving through target validation and compound optimization all the way to the clinic," he said.

The enzyme is involved in the metabolism of arachidonic acid, a key signaling molecule implicated in diabetes, hypertension and inflammatory disorders. "It's an enzyme in the same arachidonic biochemical pathway where many other common pharmaceuticals such as aspirin, Advil, Aleve, Ibuprofen, Motrin and other are active," he said.

Phase 1 evaluated the safety, safe dosage range and side effects of the drug candidate. It then entered Phase IIa.

UC Davis physicians and scientists praised the new drug as promising. Nephrologist and cell biologist Robert Weiss of the UC Davis Health System said the drug could lead to important health implications for patients with type 2 diabetes, a chronic disease affecting an estimated 23.6 million children and adults in the United States.

"Both diabetes and hypertension are often associated with vascular inflammation as is atherosclerosis," Weiss said. "Last year we demonstrated that these compounds dramatically reduce atherosclerosis problem in obese mice."

"These compounds appear useful in a variety of cardiovascular disorders," said biochemist and food scientist Bruce German, UC Davis professor of food science and technology.

"Diabetes and high blood pressure commonly
'/>"/>

Contact: Kathy Keatley Garvey
kegarvey@ucdavis.edu
530-754-6894
University of California - Davis
Source:Eurekalert  

Page: 1 2 3 4 5

Related biology news :

1. UC Davis research shows that newly discovered drug reduces heart enlargement
2. UC Davis researchers find molecule that targets brain tumors
3. UC Davis discovery offers hope for treating kidney cancer
4. UC Davis team refines cancer treatments to reduce potential nerve damage
5. UC Davis researchers exploring gene therapy to fight AIDS
6. UC Davis researchers discover Achilles heel in pancreatic cancer
7. UC Davis researchers discover a key to aggressive breast cancer
8. UC Davis chemical ecologist wins major award
9. UC Davis researchers discover new drug target for inflammatory disease
10. UC Davis researchers define characteristics, treatment options for XXYY syndrome
11. UC Davis researcher leads climate-change discovery
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
UC Davis bench-to-bedside research: Promising treatment in clinical trials
(Date:6/18/2015)... -- NXT-ID, Inc. (NASDAQ: NXTD ) ("NXT-ID" or the ... commerce market announces that its Wocket® smart wallet will be ... Mark", scheduled to air on WABC Radio (am770) in ... The broadcast air- time for the extensive ... NXT-ID, Inc.,s CEO Gino Pereira will be discussing ...
(Date:6/17/2015)... GERMANTOWN, Maryland , and HILDEN, Germany ... (NASDAQ: QGEN ; Frankfurt Prime Standard: QIA) today launched ... DNA evidence in forensic laboratories in the United ... integrated solution to simultaneously analyze multiple key genomic markers (short ... Investigator ® Quality Sensor to evaluate the quality of ...
(Date:6/17/2015)... Fla. , June 17, 2015  Crossmatch™, ... today announced that its U.are.U ® 4500 ... Togo,s Eateries, Inc., a ... sandwich chain, to increase security, improve accountability and ... readers enable instant, non-repudiable identity confirmation for employee ...
Breaking Biology News(10 mins):NXT-ID, Inc.'s CEO Gino Pereira Talks About the Wocket Smart Wallet on WABC Radio, New York City, June 20th 2NXT-ID, Inc.'s CEO Gino Pereira Talks About the Wocket Smart Wallet on WABC Radio, New York City, June 20th 3QIAGEN Launches New Genetic Fingerprinting Kits for U.S. Forensic Labs 2QIAGEN Launches New Genetic Fingerprinting Kits for U.S. Forensic Labs 3QIAGEN Launches New Genetic Fingerprinting Kits for U.S. Forensic Labs 4QIAGEN Launches New Genetic Fingerprinting Kits for U.S. Forensic Labs 5Togo's Eateries Improve Security and Accountability with Crossmatch Fingerprint Readers 2Togo's Eateries Improve Security and Accountability with Crossmatch Fingerprint Readers 3
... Sildenafil and other "impotence drugs" that boost the production of ... an erection now also show promise in unmasking cancer cells ... say scientists at the Johns Hopkins Kimmel Cancer Center. , ... tumors showed that tumor size decreased two- and threefold in ...
... many as 18 percent of adults who have no history ... stroke, according to results of a large national study published ... one of the JAMA/Archives journals. , Using brain imaging to ... have had an undiagnosed or silent stroke, according to background ...
... in imaging software and machinery, also known as a 64-slice ... and accurate means of tracking blood that has been slowed ... it took them less than half the time of exercise ... warning of vessels more likely to become blocked and cause ...
Cached Biology News:'Erectile dysfunction' drugs heighten natural anti-cancer activity 2Stroke symptoms common among general population 2Fast test for low blood flow in dogs detects early heart trouble 2Fast test for low blood flow in dogs detects early heart trouble 3Fast test for low blood flow in dogs detects early heart trouble 4
(Date:6/26/2015)... -- The report "Biolubricants Market by Type ... Chainsaw oils, Mold Release Agents), End Use (Industrial, Commercial ... and Forecasts to 2020" published by MarketsandMarkets, The Biolubricants ... at a CAGR of 6.27% between 2015 and 2020. ...   66 Figures spread through 170 Pages and in-depth ...
(Date:6/25/2015)... -- Current asthma medications, which work by suppressing ... the airways, can stop working over time. A ... Hospital and Harvard Medical School supports a surprising ... nerve endings in the lungs that help drive ... journal Neuron on June 25, the ...
(Date:6/25/2015)... 25, 2015  The Galien Awards Committee announced today ... and Medical Genetics at the University of Washington and ... Award at the ninth annual Prix Galien ... The Pro Bono Humanum Award recognizes ground-breaking efforts ... woman recipient of the award.   The Galien ...
(Date:6/25/2015)... San Francisco, CA (PRWEB) , ... June 25, ... ... the uBiome Studies Portal to support citizen science opportunities in microbiome research, on ... is a microbiome sequencing service that made history with a record-breaking campaign to ...
Breaking Biology Technology:Biolubricants Market Worth $2,972.13 Million by 2020 2Biolubricants Market Worth $2,972.13 Million by 2020 3Targeting Nerve Endings To Curb Allergic Asthma 2Targeting Nerve Endings To Curb Allergic Asthma 3Targeting Nerve Endings To Curb Allergic Asthma 4Targeting Nerve Endings To Curb Allergic Asthma 5The Prix Galien USA Awards Committee Selects Professor Mary-Claire King as 2015 Pro Bono Humanum Honoree 2The Prix Galien USA Awards Committee Selects Professor Mary-Claire King as 2015 Pro Bono Humanum Honoree 3uBiome Launches Studies Portal to Support Microbiome Research 2uBiome Launches Studies Portal to Support Microbiome Research 3
... NEW YORK, Aug. 1, 2011 /PRNewswire-Asia-FirstCall/ -- American Oriental ... or "AOBO"), a pharmaceutical company dedicated to improving health ... range of prescription and over the counter ("OTC") products, ... 2011 financial results on Tuesday, August 9, 2011, after ...
... Researchers have developed a toolkit that enables them to ... Led by Susan Dymecki, a professor of ... serotonin-producing neurons, observing how mice behave in a normal ... While their findings affirm earlier studies, the researchers used ...
... When normal proteins form protein clumps in the body, ... "amyloids," are closely associated with Alzheimer,s disease and type ... knew how these proteins form clumps, then they might ... The physicist Adrian Keller and his colleagues at the ...
Cached Biology Technology:American Oriental Bioengineering to Announce Second Quarter 2011 Financial Results on August 9, 2011 2Researchers target, switch off serotonin-producing neurons in mice 2Researchers target, switch off serotonin-producing neurons in mice 3In the pursuit of dangerous clumps 2In the pursuit of dangerous clumps 3
Identify and characterize Phosphoinositide (PI(4,5)P2) binding...
Recommended fro Western blotting application...
... Immunogen corresponds to amino acids 2-105 ... has been successfully used in Western blot, ... blot, this antibody detects an ~ 60 ... has also been used in immunoprecipitation and ...
... KLF15 is a Cys2-His2 zinc finger gene. ... liver, kidneys, heart, and skeletal muscle. ... produced in rabbits immunized with a synthetic ... KLF15 with an internal ID of P03590 ...
Biology Products: